Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomideIris Maria Forte, Antonio Giordano|International Journal of Oncology|2019Cited by 42
Caprine herpesvirus 1 (CpHV-1) as a potential candidate for oncolytic virotherapySerena Montagnaro, Ugo Pagnini, Roberto Ciarcia et al.|Cancer Biology & Therapy|2018Cited by 19
The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy ApproachIris Maria Forte, Roberto Ciarcia, Paola Indovina et al.|Viruses|2021Cited by 18